Evidence map›Paper›PMID 25522363›Full record

ArticlePloS one2014

Functional cardiomyocytes derived from Isl1 cardiac progenitors via Bmp4 stimulation.

Esra Cagavi, Oscar Bartulos, Carol Y Suh, Baonan Sun, Zhichao Yue, Zhengxin Jiang, Lixia Yue, Yibing Qyang

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Discovery and functional investigation ofAmerican journal of translational research · 2024
    Article
  5. Review
  6. The Role of the TGF-β Superfamily in Myocardial Infarction.Frontiers in cardiovascular medicine · 2019
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Esra CagaviYale Cardiovascular Research Center, Section of Cardiovascular Medicine, Department of Internal Medicine, Yale Stem Cell Center, Yale School of Medicine, Yale University, New Haven, CT, United States of America; Department of Medical Biology, School of Medicine, Istanbul Medipol University, Istanbul, Turkey.
Oscar BartulosYale Cardiovascular Research Center, Section of Cardiovascular Medicine, Department of Internal Medicine, Yale Stem Cell Center, Yale School of Medicine, Yale University, New Haven, CT, United States of America.
Carol Y SuhYale Cardiovascular Research Center, Section of Cardiovascular Medicine, Department of Internal Medicine, Yale Stem Cell Center, Yale School of Medicine, Yale University, New Haven, CT, United States of America; Department of Genetics, Yale School of Medicine, Yale University, New Haven, CT, United States of America.
Baonan SunDepartment of Cell Biology, University of Connecticut Health Center, Farmington, CT, United States of America.
Zhichao YueDepartment of Cell Biology, University of Connecticut Health Center, Farmington, CT, United States of America.
Zhengxin JiangYale Cardiovascular Research Center, Section of Cardiovascular Medicine, Department of Internal Medicine, Yale Stem Cell Center, Yale School of Medicine, Yale University, New Haven, CT, United States of America.
Lixia YueDepartment of Cell Biology, University of Connecticut Health Center, Farmington, CT, United States of America.
Yibing QyangYale Cardiovascular Research Center, Section of Cardiovascular Medicine, Department of Internal Medicine, Yale Stem Cell Center, Yale School of Medicine, Yale University, New Haven, CT, United States of America; Department of Pathology, Yale School of Medicine, New Haven, CT, United States of America; Vascular Biology and Therapeutics Program, Yale University School of Medicine, New Haven, CT, United States of America.
Yale University · USUConn Health · USIstanbul Medipol University · TR

Funding

Yale Pathology Tissue Services Shared ResourceP30CA016359 · NCI · YALE UNIVERSITY · PI DAVID L RIMM · 1985 to 2026
$85.0M
YALE UNIVERSITY CLINICAL AND TRANSLATIONAL SCIENCE AWARD PROGRAMUL1RR024139 · NCRR · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2006 to 2011
$56.8M
Yale University Clinical and Translational Science Award ProgramUL1TR000142 · NCATS · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2012 to 2015
$31.8M
Ca2+ signaling mechanisms in cardiac fibrosisR01HL078960 · NHLBI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI YUE, LIXIA · 2005 to 2015
$3.9M
Human tissue-engineered blood vessels using induced pluripotent stem cellsR01HL116705 · NHLBI · YALE UNIVERSITY · PI QYANG, YIBING · 2013 to 2017
$2.0M
Derivation of Heart Cells from Human Embryonic and Induced Pluripotent Stem CellsK02HL101990 · NHLBI · YALE UNIVERSITY · PI QYANG, YIBING · 2010 to 2014
$489k
NCATS NIH HHS UL1 TR000142NCRR NIH HHS UL1 RR024139NHLBI NIH HHS 1K02HL116705-01NHLBI NIH HHS K02 HL101990NHLBI NIH HHS R01 HL078960NHLBI NIH HHS R01HL078960NHLBI NIH HHS R01 HL116705
6 · The paper itself

Abstract

As heart failure due to myocardial infarction remains a leading cause of morbidity worldwide, cell-based cardiac regenerative therapy using cardiac progenitor cells (CPCs) could provide a potential treatment for the repair of injured myocardium. As adult CPCs may have limitations regarding tissue accessibility and proliferative ability, CPCs derived from embryonic stem cells (ESCs) could serve as an unlimited source of cells with high proliferative ability. As one of the CPCs that can be derived from embryonic stem cells, Isl1 expressing cardiac progenitor cells (Isl1-CPCs) may serve as a valuable source of cells for cardiac repair due to their high cardiac differentiation potential and authentic cardiac origin. In order to generate an unlimited number of Isl1-CPCs, we used a previously established an ESC line that allows for isolation of Isl1-CPCs by green fluorescent protein (GFP) expression that is directed by the mef2c gene, specifically expressed in the Isl1 domain of the anterior heart field. To improve the efficiency of cardiac differentiation of Isl1-CPCs, we studied the role of Bmp4 in cardiogenesis of Isl1-CPCs. We show an inductive role of Bmp directly on cardiac progenitors and its enhancement on early cardiac differentiation of CPCs. Upon induction of Bmp4 to Isl1-CPCs during differentiation, the cTnT+ cardiomyocyte population was enhanced 2.8±0.4 fold for Bmp4 treated CPC cultures compared to that detected for vehicle treated cultures. Both Bmp4 treated and untreated cardiomyocytes exhibit proper electrophysiological and calcium signaling properties. In addition, we observed a significant increase in Tbx5 and Tbx20 expression in differentiation cultures treated with Bmp4 compared to the untreated control, suggesting a link between Bmp4 and Tbx genes which may contribute to the enhanced cardiac differentiation in Bmp4 treated cultures. Collectively these findings suggest a cardiomyogenic role for Bmp4 directly on a pure population of Isl1 expressing cardiac progenitors, which could lead to enhancement of cardiac differentiation and engraftment, holding a significant therapeutic value for cardiac repair in the future.

Indexed as

Cell DifferentiationAction PotentialsAnimalsBone Morphogenetic Protein 4Calcium SignalingCell LineEmbryonic Stem CellsLIM-Homeodomain ProteinsMiceMyocytes, CardiacT-Box Domain ProteinsTranscription FactorsBone Morphogenetic Protein 4insulin gene enhancer binding protein Isl-1LIM-Homeodomain ProteinsT-Box Domain ProteinsT-box transcription factor 5Tbx20 protein, mouseTranscription Factors

Identifiers

PMID25522363
PMCPMC4270687
OpenAlexW2144990878

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.